UNSPSC 51453006: Piperazine citrate anhydrous

This classification denotes an antihelminthic agent with the molecular formula 2C6H8O7.3C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RI85381D5G, chemically known as piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), but more generally known as piperazine citrate anhydrous, which bears US NIH Compound Identifier 114763. European Medicines Agency schedules piperazine citrate anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG.

Most nations, for tariff purposes, schedule piperazine citrate anhydrous under HS 29335990. SMILES: C1CNCCN1.C1CNCCN1.C1CNCCN1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51453006 Pipemazine citrate anhydrous is a Commodity code that covers pharmaceutical active ingredients and finished pharmaceutical products procured by state and local health agencies. Recent state and local opportunities tagged to this code show activity in pharmaceutical warehouse supply and emergency medical countermeasures, though the opportunities diverge significantly from the code's nominal focus on a single active ingredient. State health departments and county public health authorities are the primary issuing bodies; the Illinois Department of Public Health and Seminole County, Florida both appear in recent postings. Scope of work includes bulk pharmaceutical procurement through piggyback cooperative purchasing agreements and direct purchase of finished medical products including antibiotic tablets and emergency response supplies such as naloxone and drug deactivation systems, typically with multi-year terms and quarterly or regular delivery schedules.

Illinois and Florida drive recent activity under this code. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over 12 months with renewal options. Seminole County, Florida issued an IFB on June 30, 2026 (IFB60459723LAS) seeking 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, response deadline July 26, 2026. Both procurements use competitive bidding and include multi-year terms. The tag mismatch between the code name (piperazine citrate anhydrous) and the actual pharmaceutical products being purchased signals that state and local procurement systems may use this code broadly for pharmaceutical supply chain activity rather than for a single active ingredient.